Summary & Overview
HCPCS J0668: Instillation of Bupivacaine and Meloxicam, 1 mg/0.03 mg
HCPCS Level II code J0668 denotes the instillation of a combined bupivacaine and meloxicam formulation (1 mg/0.03 mg). The code captures a specific medication administration service used to provide localized analgesia with anti-inflammatory effect during or after procedures. Nationally, accurate coding of such combination-agent instillations is important for clinical documentation, claims processing, and monitoring utilization of newer or compounded therapeutic options.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides benchmarking context for coverage and payment patterns, summarizes clinical purpose and typical sites of service, and highlights common billing considerations where input data are available. Readers will find a concise explanation of the clinical context for J0668, an overview of what payers commonly review when adjudicating claims for instilled analgesic/anti-inflammatory agents, and identification of areas where additional documentation or coding specificity may be relevant.
Data not available in the input for some fields such as associated taxonomies, ICD-10 diagnoses, detailed payer policies, and related codes. The report is written for a national audience and focuses on the code definition, clinical use, and the payer landscape.
Billing Code Overview
HCPCS Level II code J0668 describes an instillation of a combined local anesthetic and anti-inflammatory formulation: bupivacaine and meloxicam, dosed at 1 mg/0.03 mg. This code represents a medication administration service in which the specified compounded or combination agent is instilled for analgesic and anti-inflammatory effect.
Service type: Medication instillation / injectable therapeutic administration
Typical site of service: Outpatient procedure areas, ambulatory surgery centers, or hospital outpatient departments, and may also be used in other procedural settings where instillation of therapeutic agents is performed.
Clinical & Coding Specifications
Clinical Context
A patient presents to an ambulatory surgery center or hospital outpatient department for intraoperative or intra-articular analgesia following a minor surgical procedure or joint arthroscopy. The clinician prepares an instillation of combined bupivacaine and meloxicam, billed as J0668 per incremental unit (1 mg/0.03 mg). Typical indications include postoperative pain control after knee arthroscopy, shoulder arthroscopy, small joint procedures, or local infiltration for soft-tissue procedures. The workflow: preoperative evaluation documents indication, allergies, and consent; intraoperative administration of the instillation is performed by the surgeon or proceduralist into the surgical site or joint space after hemostasis; administration details (dose, lot, route, time) are recorded in the operative note and medication administration record; postoperative orders address monitoring for local anesthetic systemic toxicity and NSAID-related risks; billing uses J0668 with any applicable modifier(s) and links to the operative CPT and relevant ICD-10 diagnosis codes on the claim.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
AS | Patient is an ambulatory surgical patient | Use when patient is in an ambulatory surgery center and payer requires for facility status |